메뉴 건너뛰기




Volumn 32, Issue 21, 2007, Pages 2294-2299

Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model

Author keywords

Animal model; Bone morphogenetic protein; EP4 receptor agonist; Spinal fusion

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHEMICAL COMPOUND; POLYMER; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN EP4 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

EID: 34848828230     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318154c5b6     Document Type: Article
Times cited : (22)

References (40)
  • 1
  • 3
  • 4
    • 0024832051 scopus 로고
    • Harvesting autogenous iliac bone grafts: A review of complications and techniques
    • Kurz LT, Garfin SR, Booth RE Jr. Harvesting autogenous iliac bone grafts: a review of complications and techniques. Spine 1989;14:1324-31.
    • (1989) Spine , vol.14 , pp. 1324-1331
    • Kurz, L.T.1    Garfin, S.R.2    Booth Jr., R.E.3
  • 5
    • 0033954803 scopus 로고    scopus 로고
    • The use of rhBMP-2 in interbody fusion cages: Definitive evidence of osteoinduction in humans: a preliminary report
    • Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81.
    • (2000) Spine , vol.25 , pp. 376-381
    • Boden, S.D.1    Zdeblick, T.A.2    Sandhu, H.S.3
  • 6
    • 0036815167 scopus 로고    scopus 로고
    • Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages
    • Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337-49.
    • (2002) J Spinal Disord Tech , vol.15 , pp. 337-349
    • Burkus, J.K.1    Gornet, M.F.2    Dickman, C.A.3
  • 7
    • 0032556891 scopus 로고    scopus 로고
    • Last chance to stop and think on risks of xenotransplants
    • Butler D. Last chance to stop and think on risks of xenotransplants. Nature 1998;391:320-4.
    • (1998) Nature , vol.391 , pp. 320-324
    • Butler, D.1
  • 8
    • 0025066426 scopus 로고
    • Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives
    • DeLustro F, Dasch J, Keefe J, et al. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop 1990;263-79.
    • (1990) Clin Orthop , pp. 263-279
    • DeLustro, F.1    Dasch, J.2    Keefe, J.3
  • 9
    • 0036836440 scopus 로고    scopus 로고
    • Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer
    • Murakami N, Saito N, Horiuchi H, et al. Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer. J Biomed Mater Res 2002;62:169-74.
    • (2002) J Biomed Mater Res , vol.62 , pp. 169-174
    • Murakami, N.1    Saito, N.2    Horiuchi, H.3
  • 10
    • 0037409988 scopus 로고    scopus 로고
    • Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier
    • Murakami N, Saito N, Takahashi J, et al. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 2003;24:2153-9.
    • (2003) Biomaterials , vol.24 , pp. 2153-2159
    • Murakami, N.1    Saito, N.2    Takahashi, J.3
  • 11
    • 33646026111 scopus 로고    scopus 로고
    • Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2
    • Kato M, Namikawa T, Terai H, et al. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. Biomaterials 2006;27:3927-33.
    • (2006) Biomaterials , vol.27 , pp. 3927-3933
    • Kato, M.1    Namikawa, T.2    Terai, H.3
  • 12
    • 28744441817 scopus 로고    scopus 로고
    • Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2)
    • Kato M, Toyoda H, Namikawa T, et al. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 2006;27:2035-41.
    • (2006) Biomaterials , vol.27 , pp. 2035-2041
    • Kato, M.1    Toyoda, H.2    Namikawa, T.3
  • 13
    • 4344644450 scopus 로고    scopus 로고
    • A new bone-inducing biodegradable porous beta-tricalcium phosphate
    • Matsushita N, Terai H, Okada T, et al. A new bone-inducing biodegradable porous beta-tricalcium phosphate. J Biomed Mater Res A 2004;70:450-8.
    • (2004) J Biomed Mater Res A , vol.70 , pp. 450-458
    • Matsushita, N.1    Terai, H.2    Okada, T.3
  • 14
    • 0035066563 scopus 로고    scopus 로고
    • A biodegradable polymer as a cytokine delivery system for inducing bone formation
    • Saito N, Okada T, Horiuchi H, et al. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 2001;19:332-5.
    • (2001) Nat Biotechnol , vol.19 , pp. 332-335
    • Saito, N.1    Okada, T.2    Horiuchi, H.3
  • 15
    • 0037409732 scopus 로고    scopus 로고
    • New synthetic biodegradable polymers as BMP carriers for bone tissue engineering
    • Saito N, Takaoka K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 2003;24:2287-93.
    • (2003) Biomaterials , vol.24 , pp. 2287-2293
    • Saito, N.1    Takaoka, K.2
  • 16
    • 15344347281 scopus 로고    scopus 로고
    • Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant
    • Yoneda M, Terai H, Imai Y, et al. Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant. Biomaterials 2005;26:5145-52.
    • (2005) Biomaterials , vol.26 , pp. 5145-5152
    • Yoneda, M.1    Terai, H.2    Imai, Y.3
  • 17
    • 23244447834 scopus 로고    scopus 로고
    • Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model
    • Namikawa T, Terai H, Suzuki E, et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine 2005;30:1717-22.
    • (2005) Spine , vol.30 , pp. 1717-1722
    • Namikawa, T.1    Terai, H.2    Suzuki, E.3
  • 18
    • 2442537090 scopus 로고    scopus 로고
    • A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2
    • Sasaoka R, Terai H, Toyoda H, et al. A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 2004;318:704-9.
    • (2004) Biochem Biophys Res Commun , vol.318 , pp. 704-709
    • Sasaoka, R.1    Terai, H.2    Toyoda, H.3
  • 19
    • 24944446761 scopus 로고    scopus 로고
    • Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist
    • Toyoda H, Terai H, Sasaoka R, et al. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone 2005;37:555-62.
    • (2005) Bone , vol.37 , pp. 555-562
    • Toyoda, H.1    Terai, H.2    Sasaoka, R.3
  • 20
    • 0028965181 scopus 로고
    • An experimental lumbar intertransverse process spinal fusion model: Radiographic, histologic, and biomechanical healing characteristics
    • Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:412-20.
    • (1995) Spine , vol.20 , pp. 412-420
    • Boden, S.D.1    Schimandle, J.H.2    Hutton, W.C.3
  • 21
    • 0037342898 scopus 로고    scopus 로고
    • Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion
    • Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;28:429-34.
    • (2003) Spine , vol.28 , pp. 429-434
    • Akamaru, T.1    Suh, D.2    Boden, S.D.3
  • 22
    • 0033565907 scopus 로고    scopus 로고
    • Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2
    • Itoh H, Ebara S, Kamimura M, et al. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999;24:1402-5.
    • (1999) Spine , vol.24 , pp. 1402-1405
    • Itoh, H.1    Ebara, S.2    Kamimura, M.3
  • 23
    • 0036069440 scopus 로고    scopus 로고
    • Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion
    • Konishi S, Nakamura H, Seki M, et al. Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion. J Spinal Disord Tech 2002;15:237-44.
    • (2002) J Spinal Disord Tech , vol.15 , pp. 237-244
    • Konishi, S.1    Nakamura, H.2    Seki, M.3
  • 24
    • 0035871020 scopus 로고    scopus 로고
    • Evaluation of carriers of bone morphogenetic protein for spinal fusion
    • Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001;26:933-9.
    • (2001) Spine , vol.26 , pp. 933-939
    • Minamide, A.1    Kawakami, M.2    Hashizume, H.3
  • 25
    • 0029740478 scopus 로고    scopus 로고
    • Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion
    • Sandhu HS, Kanim LE, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-22.
    • (1996) Spine , vol.21 , pp. 2115-2122
    • Sandhu, H.S.1    Kanim, L.E.2    Kabo, J.M.3
  • 26
    • 0029073098 scopus 로고
    • Experimental spinal fusion with recombinant human bone morphogenetic protein-2
    • Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
    • (1995) Spine , vol.20 , pp. 1326-1337
    • Schimandle, J.H.1    Boden, S.D.2    Hutton, W.C.3
  • 27
    • 0037082557 scopus 로고    scopus 로고
    • Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate
    • Suh DY, Boden SD, Louis-Ugbo J, et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine 2002;27:353-60.
    • (2002) Spine , vol.27 , pp. 353-360
    • Suh, D.Y.1    Boden, S.D.2    Louis-Ugbo, J.3
  • 28
    • 9244219629 scopus 로고    scopus 로고
    • Prostaglandin E receptor subtypes in mouse osteoblastic cell line
    • Suda M, Tanaka K, Natsui K, et al. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 1996;137:1698-705.
    • (1996) Endocrinology , vol.137 , pp. 1698-1705
    • Suda, M.1    Tanaka, K.2    Natsui, K.3
  • 29
    • 0029093450 scopus 로고
    • Expression of prostaglandin E receptor subtypes in bone: Expression of EP2 in bone development
    • Kasugai S, Oida S, Iimura T, et al. Expression of prostaglandin E receptor subtypes in bone: expression of EP2 in bone development. Bone 1995;17:1-4.
    • (1995) Bone , vol.17 , pp. 1-4
    • Kasugai, S.1    Oida, S.2    Iimura, T.3
  • 30
    • 33645371513 scopus 로고    scopus 로고
    • A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats
    • Ke HZ, Crawford DT, Qi H, et al. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. J Bone Miner Res 2006;21:565-75.
    • (2006) J Bone Miner Res , vol.21 , pp. 565-575
    • Ke, H.Z.1    Crawford, D.T.2    Qi, H.3
  • 31
    • 10744220089 scopus 로고    scopus 로고
    • A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing
    • Li M, Ke HZ, Qi H, et al. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003;18:2033-42.
    • (2003) J Bone Miner Res , vol.18 , pp. 2033-2042
    • Li, M.1    Ke, H.Z.2    Qi, H.3
  • 32
    • 0036009724 scopus 로고    scopus 로고
    • Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice
    • Li X, Pilbeam CC, Pan L, et al. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 2002;30:567-73.
    • (2002) Bone , vol.30 , pp. 567-573
    • Li, X.1    Pilbeam, C.C.2    Pan, L.3
  • 33
    • 0034954444 scopus 로고    scopus 로고
    • Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2)
    • Machwate M, Harada S, Leu CT, et al. Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol 2001;60:36-41.
    • (2001) Mol Pharmacol , vol.60 , pp. 36-41
    • Machwate, M.1    Harada, S.2    Leu, C.T.3
  • 34
    • 0038651097 scopus 로고    scopus 로고
    • An EP2 receptor-selective prostaglandin E2 agonist induces bone healing
    • Paralkar VM, Borovecki F, Ke HZ, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA 2003;100:6736-40.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 6736-6740
    • Paralkar, V.M.1    Borovecki, F.2    Ke, H.Z.3
  • 35
    • 0942300649 scopus 로고    scopus 로고
    • A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro
    • Shamir D, Keila S, Weinreb M. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 2004;34:157-62.
    • (2004) Bone , vol.34 , pp. 157-162
    • Shamir, D.1    Keila, S.2    Weinreb, M.3
  • 36
    • 2942548967 scopus 로고    scopus 로고
    • Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats
    • Tanaka M, Sakai A, Uchida S, et al. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004;34:940-8.
    • (2004) Bone , vol.34 , pp. 940-948
    • Tanaka, M.1    Sakai, A.2    Uchida, S.3
  • 37
    • 0035126685 scopus 로고    scopus 로고
    • Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue
    • Weinreb M, Machwate M, Shir N, et al. Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue. Bone 2001;28:275-81.
    • (2001) Bone , vol.28 , pp. 275-281
    • Weinreb, M.1    Machwate, M.2    Shir, N.3
  • 38
    • 0037007077 scopus 로고    scopus 로고
    • Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
    • Yoshida K, Oida H, Kobayashi T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 2002;99:4580-5.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 4580-4585
    • Yoshida, K.1    Oida, H.2    Kobayashi, T.3
  • 39
    • 0036210155 scopus 로고    scopus 로고
    • Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2
    • Horiuchi H, Saito N, Kinoshita T, et al. Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2. Bone 2002;30:589-93.
    • (2002) Bone , vol.30 , pp. 589-593
    • Horiuchi, H.1    Saito, N.2    Kinoshita, T.3
  • 40
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    • Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
    • (2001) N Engl J Med , vol.344 , pp. 1434-1441
    • Neer, R.M.1    Arnaud, C.D.2    Zanchetta, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.